Doctors must warn women HRT treatment for menopause increases risk of cancer
DOCTORS must warn women of the cancer risks of taking HRT for menopause symptoms, health chiefs have said.
But the National Institute of Health and Care Excellence said hormone replacement therapy should still be offered widely.
Research suggests the medication can slightly raise the danger of breast, womb and ovarian cancers, as well as dementia.
Nice has now issued the first “discussion aid” to help GPs and patients discuss any perils.
Chief medical officer Professor Jonathan Benger said: “We don’t routinely produce patient decision support tools but have on this occasion because of the complexity and because of the risks.
“What we’ve tried to do is show in a way that will be readily understood what the risks of key conditions are with and without HRT.
“Being able to have an informed conversation is very important.”
The Sun has spent years calling for greater support for women with our Fabulous Menopause Matters campaign.
HRT is prescribed to tackle hot flushes, night sweats, mood swings and sleep problems.
Nice ruled: “While there are some increased risks associated with HRT, it is unlikely to decrease overall life expectancy.”